Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.

Song M, Konijeti GG, Yuan C, Ananthakrishnan AN, Ogino S, Fuchs CS, Giovannucci EL, Ng K, Chan AT.

Cancer Prev Res (Phila). 2016 Aug;9(8):664-72. doi: 10.1158/1940-6207.CAPR-16-0053. Epub 2016 May 31.

PMID:
27246684
2.

Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study.

Zhu X, Liang J, Shrubsole MJ, Ness RM, Cai Q, Long J, Chen Z, Li G, Wiese D, Zhang B, Smalley WE, Edwards TL, Giovannucci E, Zheng W, Dai Q.

J Nutr. 2014 Nov;144(11):1734-41. doi: 10.3945/jn.114.196709. Epub 2014 Aug 27.

3.

Plasma 25-hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markers.

Song M, Wu K, Chan AT, Fuchs CS, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2175-80. doi: 10.1158/1055-9965.EPI-14-0712. Epub 2014 Aug 8.

4.

New perspectives on vitamin D food fortification based on a modeling of 25(OH)D concentrations.

Brown J, Sandmann A, Ignatius A, Amling M, Barvencik F.

Nutr J. 2013 Nov 21;12(1):151. doi: 10.1186/1475-2891-12-151.

5.

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.

Sperati F, Vici P, Maugeri-Saccà M, Stranges S, Santesso N, Mariani L, Giordano A, Sergi D, Pizzuti L, Di Lauro L, Montella M, Crispo A, Mottolese M, Barba M.

PLoS One. 2013 Jul 22;8(7):e69269. doi: 10.1371/journal.pone.0069269. Print 2013. Review.

6.

Vitamin D for health: a global perspective.

Hossein-nezhad A, Holick MF.

Mayo Clin Proc. 2013 Jul;88(7):720-55. doi: 10.1016/j.mayocp.2013.05.011. Epub 2013 Jun 18.

7.

Effect of sunlight exposure on serum 25-hydroxyvitamin d concentration in women with vitamin d deficiency: using ambulatory lux meter and sunlight exposure questionnaire.

Lee SH, Park SJ, Kim KM, Lee DJ, Kim WJ, Park RW, Joo NS.

Korean J Fam Med. 2012 Nov;33(6):381-9. doi: 10.4082/kjfm.2012.33.6.381. Epub 2012 Nov 27.

8.

Dietary cholecalciferol and calcium levels in a Western-style defined rodent diet alter energy metabolism and inflammatory responses in mice.

Bastie CC, Gaffney-Stomberg E, Lee TW, Dhima E, Pessin JE, Augenlicht LH.

J Nutr. 2012 May;142(5):859-65. doi: 10.3945/jn.111.149914. Epub 2012 Mar 21.

9.

Why vitamin D for cancer patients?

Gandini S, Francesco F, Johanson H, Bonanni B, Testori A.

Ecancermedicalscience. 2009;3:160. doi: 10.3332/ecancer.2009.160. Epub 2009 Sep 30.

10.

Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.

Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT.

Gastroenterology. 2012 Mar;142(3):482-9. doi: 10.1053/j.gastro.2011.11.040. Epub 2011 Dec 9.

11.

Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas.

Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, So PL, Hebert J, Bikle D, Epstein EH Jr.

Cancer Prev Res (Phila). 2011 May;4(5):744-51. doi: 10.1158/1940-6207.CAPR-10-0285. Epub 2011 Mar 24.

12.

Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.

Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, Potter JD.

Nutr Cancer. 2011;63(3):319-26. doi: 10.1080/01635581.2011.535960.

13.

Vitamin D status among adults in the Aegean region of Turkey.

Hekimsoy Z, Dinç G, Kafesçiler S, Onur E, Güvenç Y, Pala T, Güçlü F, Ozmen B.

BMC Public Health. 2010 Dec 23;10:782. doi: 10.1186/1471-2458-10-782.

14.

25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates.

Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, Sarafin K, Poliquin S, Krieger J, Richards JB, Goltzman D; CaMos Research Group..

Osteoporos Int. 2011 May;22(5):1389-99. doi: 10.1007/s00198-010-1362-7. Epub 2010 Aug 21.

15.

Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and Cancer.

Garland CF, Grant WB, Boucher BJ, Cross HS, Garland FC, Gillie O, Gorham ED, Heaney RP, Holick MF, Hollis BW, Moan JE, Peterlik M, Reichrath J, Zittermann A.

Dermatoendocrinol. 2009 Mar;1(2):119-20. No abstract available.

16.

Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study.

Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):130-4. doi: 10.1158/1055-9965.EPI-09-0475.

17.

Chemoprevention for colorectal neoplasia.

Fajardo AD, Robb BW.

Clin Colon Rectal Surg. 2008 Nov;21(4):304-12. doi: 10.1055/s-0028-1089947.

18.

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD.

J Am Soc Nephrol. 2010 Feb;21(2):353-61. doi: 10.1681/ASN.2009040451. Epub 2009 Dec 10.

19.

Calcium plus vitamin D supplementation and the risk of breast cancer.

Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; Women's Health Initiative Investigators..

J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91. doi: 10.1093/jnci/djn360. Epub 2008 Nov 11.

20.

The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

Holick MF.

Mol Aspects Med. 2008 Dec;29(6):361-8. doi: 10.1016/j.mam.2008.08.008. Epub 2008 Sep 2. Review.

Supplemental Content

Support Center